Idiopathic thrombocytopenic purpura, an approach to therapy and patient management

Idiopathic thrombocytopenic purpura (ITP), also known as primary immune thrombocytopenia, is an autoimmune disease characterized by a reduced number of platelets in the blood, leading to increased bleeding. Let's consider statistics, current concepts, pathogenesis, treatment, prevention, and follow-up of patients with ITP. ITP occurs in approximately 50-100 people per million population annually. The disease can occur at any age, but it is most often diagnosed in children and young adults. Women suffer from ITP slightly more often than men.